| 2004 | 2007 |
---|---|---|
Liberty | Â | Â |
Intellectual Property | 31.8% | 27.8% |
WTO or TRIPS | 18.5% | 14.5% |
Right of Refusal | 10.7% | 0.0% |
Developing Country Pressure | 0.5% | 2.0% |
Equity | Â | Â |
List of Medicines | 12.4% | 5.0% |
Aid | 11.5% | 23.1% |
List of Countries | 10.6% | 1.7% |
Equal Opportunity to Supply | 2.1% | 0.3% |
Efficiency | Â | Â |
Diversion | 6.1% | 2.5% |
Market Competition | 5.1% | 3.1% |
Profit and ROI | 4.5% | 3.6% |
Eligible Importers | 4.3% | 0.3% |
Procurement | 3.1% | 5.3% |
Litigation | 2.5% | 2.1% |
CAMR Outcomes and uptake | 0.0% | 21.0% |
Security | Â | Â |
Affordability | 8.3% | 12.1% |
Development | 7.5% | 11.9% |
Quality and Safety | 2.3% | 3.5% |
Innovation | 2.0% | 1.6% |
Human Rights | 1.4% | 0.4% |
Domestic Economy | 0.1% | 0.6% |
Neglected Diseases | 0.3% | 0.3% |